The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Yanimo Respimat 2.5 microgram/2.5 microgram, inhalation solution

2.5 µg/2.5 microgram(s) Inhalation solution

Boehringer Ingelheim International GmbHPA0775/010/001

Main Information

Trade NameYanimo Respimat 2.5 microgram/2.5 microgram, inhalation solution
Active SubstancesTiotropium
Olodaterol
Strength2.5 µg/2.5 microgram(s)
Dosage FormInhalation solution
Licence HolderBoehringer Ingelheim International GmbH
Licence NumberPA0775/010/001

Group Information

ATC CodeR03BB Anticholinergics
R03BB54 Anticholinergics

Status

Authorised/WithdrawnAuthorised
Licence Issued19/06/2015
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back